Replies to post #185056 on Biotech Values

[justrpaul]

It would be a rationalization if I gave it as the explanation, but as one scenario, it is just that.

More to the point, if ABBV undercut the 8 week price, they leave Gilead only one real option - to match them, and in that game, the superior product should win.